SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Lpath Inc., a San Diego-based company working on bioactive lipid-targeted therapeutics, announced that it has entered into definitive agreements to sell 3,605,042 registered shares of common stock and 3,605,042 unregistered warrants in a registered direct offering totaling $12.5 million.
Of the 100 companies featured in the Aug. 18 issue of the San Diego Business Journal named among the “Best Places to Work” in San Diego County, only ten pay 100 percent of an employee’s health insurance premiums.
Renovation of the 14,172 square foot Sharp Memorial Hospital Rehabilitation Center is now complete at the location in Kearny Mesa.
BIOTECH: Product’s First Target is Poultry Processing
Pure Bioscience Inc., a company in El Cajon, has acquired $7.9 million in private financing to continue development of its nontoxic antimicrobial, SDC, which can be sprayed directly on food to kill harmful bacteria such as salmonella and E. coli.
Precision One Medical Inc., a privately-held manufacturer of dental implants and components in Oceanside, was acquired by BioHorizons, an Alabama company that operates in the same industry.
Isis Pharmaceuticals Inc. announced that it has earned a $4 million milestone payment from San Fransisco-based Achaogen Inc. associated with the initiation of a Phase 3 study of plazomicin in patients with serious multi-drug resistant bacterial infections.
Imagenetix Inc., a San Diego-based company developing over-the-counter topical creams, skincare products and nutritional supplements, announced that its post-bankruptcy Plan of Reorganization was confirmed and all provisions of the plan were approved by Judge Margaret Mann of the United States Bankruptcy Court for the Southern District of California with an effective date of September 16, 2014, enabling the company to emerge from bankruptcy.
San Diego-based Curtana Pharmaceuticals Inc. has announced that it will be relocating to Austin, Texas, following a $7.6 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT) to fund the company’s lead cancer therapy.
San Diego-based Denovo Biopharma LLC announced that it has acquired enzastaurin, a late-stage oncology drug, from Eli Lilly and Co.
San Diego-based Halozyme Therapeutics and Baxter International Inc. announced that the United States Food and Drug Administration approved Baxter’s subcutaneous treatment, HYQVIA, for adult patients with primary immunodeficiency.
ResMed, a San Diego-based company that develops medical devices for sleep apnea and other sleep-related breathing disorders, announced that its AirView compliance management is now connected to Fairview Health Services' Epic EHR system, enabling up to date delivery of sleep apnea patient data for use by the medical staff of Fairview, a network of hospitals and clinics throughout Minnesota.
The U.S. Food and Drug Administration announced that it approved a weight-loss drug developed by La Jolla-based Orexigen Therapeutics Inc.
MabVax Therapeutics Holdings Inc., a clinical stage oncology drug development company, announced that it has entered into agreements with Memorial Sloan Kettering Cancer Center and Juno Therapeutics for the development of therapeutic products using antibody targeting sequences derived from the fully-human antibodies discovered using the MabVax antibody discovery platform.
The J. Craig Venter Institute (JCVI), a not-for-profit genomic research organization, announced today that they have hired Nicole DeBerg as chief operating officer.
San Diego-based Aethlon Medical Inc. and its diagnostic subsidiary, Exosome Sciences Inc. announced that their researchers have developed and initially validated a diagnostic platform that could identify the presence of cancer in analyzed blood samples.